STRAUMANN HLDG NA SF 0,01
STRAUMANN HLDG NA SF 0,01/ CH1175448666 /
QS51
|
- -
|
Diferencia
-
|
Volumen |
Bid- |
Ask- |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
-EUR
|
-
|
-
Volumen de negocios: - |
-Volumen de oferta: - |
-Tamaño/ Volumen/ Formato de Ask: - |
18.89 mil millonesEUR |
- |
- |
Descripción de negocio
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
Consejo de gestión & Consejo de supervisión
| CEO |
| Guillaume Daniellot |
| Consejo de gestión |
| Yang Xu, Jason Forbes , Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Matthias Schupp, Sara Dalmasso, Thomas Friese, Holger Haderer, Florian Kirsch |
| Consejo de supervisión |
| Petra Rumpf, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol |
Datos de la empresa
| Nombre: |
Straumann Holding AG |
| Dirección: |
Peter Merian-Weg 12,CH-4052 Basel |
| Teléfono: |
+41-61-965-1111 |
| Fax: |
+41-61-965-1101 |
| E-mail: |
info@straumann.com
|
| Internet: |
www.straumann.com |
| Industria: |
Healthcare |
| Sector: |
Medical Products |
| Subsector: |
Advanced Medical Devices |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
57.90% |
| Fecha de OPI: |
01/01/1998 |
Calendario de la empresa
|
CW 8 | 19/02/2025
4th Quarter/Annual Report
|
